Medicinal Nicotine for Preventing Cue Induced Craving

• Status: Completed
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if changing the timeframe (relative to cue presentation) at which the nicotine lozenge is given can attenuate the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with smoking cues. In this cross-over study, all subjects attend three laboratory sessions at which either nicotine lozenge or placebo is given prior to presentation of smoking cues or after presentation of smoking cues. The order in which the three conditions will be presented are randomized.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Smoking a minimum number of cigarettes per day

• General good health

Exclusion Criteria:

• unstable medical or psychiatric conditions

• history of severe motion sickness (due to virtual reality equipment used to present cues)

• women who are pregnant or breast feeding

The investigators will evaluate if there are other reasons why someone may not participate